Presentation is loading. Please wait.

Presentation is loading. Please wait.

Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:1851-1857.

Published byLetitia Oliver Modified over 8 years ago

Similar presentations

Presentation on theme: "Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:1851-1857."— Presentation transcript:

1 Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:1851-1857

2 Correlation Between Baseline QCA Data and Baseline IVUS Data for Matched Segments in the IVUS-Related Artery Colin Berry, et al. Circulation 2007;115:1851-1857

3 Correlation Between Baseline QCA Data in All Coronary Arteries and Baseline IVUS Data in a Single Artery Colin Berry, et al. Circulation 2007;115:1851-1857

4 Correlation between the coronary artery score on QCA and total lumen volume on IVUS at baseline Colin Berry, et al. Circulation 2007;115:1851-1857

5 Correlation Between Change in QCA Measures in the IVUS-Related Artery and Change in Plaque Volume on IVUS Colin Berry, et al. Circulation 2007;115:1851-1857

6 Correlation Between Change in QCA Measures for All Segments and Change in Plaque Volume on IVUS Colin Berry, et al. Circulation 2007;115:1851-1857

7 Correlation Between Change in QCA Measures in the IVUS-Related Artery and Change in Percent Atheroma Volume on IVUS Colin Berry, et al. Circulation 2007;115:1851-1857

8 Correlation Between Change in QCA Measures for All Segments and Change in Percent Atheroma Volume on IVUS Colin Berry, et al. Circulation 2007;115:1851-1857

9 Comparison of IVUS Results in Patients With Angiographic Progression Versus No Progression by QCA in the IVUS-Related Artery Colin Berry, et al. Circulation 2007;115:1851-1857

10 Changes in Plaque Volume* on IVUS From Baseline to Follow-Up According to 3 Values of Baseline Plaque Volume Colin Berry, et al. Circulation 2007;115:1851-1857

Download ppt "Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:1851-1857."

Similar presentations

Sibbing D, et al. J Am Coll Cardiol 2009;53:849-56.

Sibbing D, et al. J Am Coll Cardiol 2009;53:
Reversing Atherosclerosis with Aggressive Lipid Lowering Reversing Atherosclerosis with Aggressive Lipid Lowering Presented at American Heart Association.

Reversing Atherosclerosis with Aggressive Lipid Lowering Reversing Atherosclerosis with Aggressive Lipid Lowering Presented at American Heart Association.
IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.

IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.
IVUS-VH & Vulnerable Plaque Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon City, S. Korea Jang-Ho Bae, MD., PhD. Heart Center.

IVUS-VH & Vulnerable Plaque Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon City, S. Korea Jang-Ho Bae, MD., PhD. Heart Center.
1 CAMELOT: Study Design A Morbidity and Mortality Study Patients with documented CAD on standard-of-care therapies* (n=1997) Clinical events (morbidity.

1 CAMELOT: Study Design A Morbidity and Mortality Study Patients with documented CAD on standard-of-care therapies* (n=1997) Clinical events (morbidity.
Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.

Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.
Effect of Rosuvastatin Therapy on Coronary Artery Stenosis Assessed by Quantitative Coronary Angiography in ASTEROID CM Ballantyne, 1 JS Raichlen, 2 SJ.

Effect of Rosuvastatin Therapy on Coronary Artery Stenosis Assessed by Quantitative Coronary Angiography in ASTEROID CM Ballantyne, 1 JS Raichlen, 2 SJ.
Slide Source: Lipids Online Slide Library www.lipidsonline.org Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients.

Slide Source: Lipids Online Slide Library Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients.
ASTEROID A Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound- Derived coronary atheroma burden.

ASTEROID A Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound- Derived coronary atheroma burden.
Clinical Trial Results. org The ERASE Trial: Effect of rHDL on Atherosclerosis-Safety and Efficacy Presented at American College of Cardiology Annual Scientific.

Clinical Trial Results. org The ERASE Trial: Effect of rHDL on Atherosclerosis-Safety and Efficacy Presented at American College of Cardiology Annual Scientific.
ASTEROID A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden   References Nissen et al. Effect.

ASTEROID A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden   References Nissen et al. Effect.
© 2012 EuroIntervention. All rights reserved. EuroIntervention 2011;7:225-233 Correlation between fractional flow reserve and intravascular ultrasound.

© 2012 EuroIntervention. All rights reserved. EuroIntervention 2011;7: Correlation between fractional flow reserve and intravascular ultrasound.
Navigating the Coronary Circulation: Angiography vs IVUS Pearls and Pitfalls Philippe L. L’Allier, MD Montreal Heart Institute Tuesday, March 27, 2007.

Navigating the Coronary Circulation: Angiography vs IVUS Pearls and Pitfalls Philippe L. L’Allier, MD Montreal Heart Institute Tuesday, March 27, 2007.
Comparison of the Progression of Coronary Atherosclerosis for Two High Efficacy Statin Regimens with Different HDL Effects: SATURN Study Results SJ Nicholls,

Comparison of the Progression of Coronary Atherosclerosis for Two High Efficacy Statin Regimens with Different HDL Effects: SATURN Study Results SJ Nicholls,
Murat Sezer, Emre Aslanger, Arif Cimen, Ebru Yormaz, Cuneyt Turkmen, Berrin Umman, Yılmaz Nisanci, Zehra Bugra and Sabahattin Umman Istanbul University,

Murat Sezer, Emre Aslanger, Arif Cimen, Ebru Yormaz, Cuneyt Turkmen, Berrin Umman, Yılmaz Nisanci, Zehra Bugra and Sabahattin Umman Istanbul University,
Ho PM, et al. JAMA 2009;301:937-44. Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:937-44.

Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:
SATURN: Objective To compare the effects of rosuvastatin 40 mg versus atorvastatin 80 mg on progression of coronary atherosclerosis assessed by intravascular.

SATURN: Objective To compare the effects of rosuvastatin 40 mg versus atorvastatin 80 mg on progression of coronary atherosclerosis assessed by intravascular.
Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:1556-1563.

Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:
When I Use IVUS Neal Uren MD FRCP Consultant Cardiologist Royal Infirmary Edinburgh.

When I Use IVUS Neal Uren MD FRCP Consultant Cardiologist Royal Infirmary Edinburgh.
Solomon Tesfaye et al N Engl J Med 2005;352:341- 50 Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Similar presentations

Ads by Google